The Combination of Immune Checkpoint Blockade with Tumor Vessel Normalization as a Promising Therapeutic Strategy for Breast Cancer: An Overview of Preclinical and Clinical Studies

Immune checkpoint inhibitors (ICIs) have a modest clinical activity when administered as monotherapy against breast cancer (BC), the most common malignancy in women. Novel combinatorial strategies are currently being investigated to overcome resistance to ICIs and promote antitumor immune responses...

Descripción completa

Detalles Bibliográficos
Autores principales: Melaiu, Ombretta, Vanni, Gianluca, Portarena, Ilaria, Pistolese, Chiara Adriana, Anemona, Lucia, Pomella, Silvia, Bei, Roberto, Buonomo, Oreste Claudio, Roselli, Mario, Mauriello, Alessandro, Barillari, Giovanni
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9964596/
https://www.ncbi.nlm.nih.gov/pubmed/36834641
http://dx.doi.org/10.3390/ijms24043226

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9964596/
https://www.ncbi.nlm.nih.gov/pubmed/36834641
http://dx.doi.org/10.3390/ijms24043226

Ejemplares similares